
Algenex SL has announced EMA validation of a recombinant subunit vaccine produced by their baculovirus vector-mediated expression platform, that harnesses …
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership

